FINANCIAL HEALTH ASSESSMENT — DYNACAST (UK) LIMITED

Company No: 03926539 | Status: Active | SIC Code: 24540 (Casting of other non-ferrous metals)

EXECUTIVE FINANCIAL HEALTH SCORE: B+

Good underlying health with strong capitalisation, though the absence of filed financial statements for the most recent period limits diagnostic certainty.

1. KEY VITAL SIGNS

Corporate Vitality

Capital Structure

Governance

2. SYMPTOMS ANALYSIS

What the Numbers Reveal

Positive Indicators (Healthy Signs):

1. Longevity & Stability: 25 years of continuous operation in the precision die-casting sector indicates resilience through multiple economic cycles. This is a company with a track record.

2. Compliance Discipline: Both accounts and confirmation statements are filed on time with no overdue obligations. This suggests sound administrative governance — a strong proxy for broader management quality.

3. Substantial Capital Base: Share capital of £100,500 is meaningful for a manufacturing operation, indicating committed shareholders with real skin in the game.

4. Group Support: Being majority-owned by Dynacast UK Parent Limited suggests access to group-level resources, technical expertise, and potentially shared services. This can provide a financial safety net.

5. Full Accounts Category: The company files full accounts rather than abridged or micro-entity accounts, indicating it exceeds the small company thresholds. This signals a business of meaningful scale.

Warning Signs (Symptoms to Monitor):

1. Recent Director Departures: Two directors resigned in February 2026. While not inherently problematic, sudden board changes at a subsidiary can signal restructuring, strategic shifts, or internal tension. Worth monitoring.

2. Absence of Recent Financial Data: The most recent accounts available are to 31 December 2025, and we have not received detailed financial statements for this assessment. This limits our ability to verify profitability, liquidity, and solvency in real terms.

3. Sector Cyclicality: Non-ferrous metal casting (typically aluminium, zinc, magnesium) is capital-intensive and sensitive to: - Raw material price volatility - Automotive and industrial demand cycles - Energy costs (particularly relevant given UK energy prices) - Global supply chain pressures

4. Subsidiary Dependency: As a controlled subsidiary, the company's strategic direction is determined by its parent. This can be a double-edged sword — providing stability but limiting local autonomy.

3. DIAGNOSIS

Overall Condition: STABLE — GOOD HEALTH WITH OBSERVATION RECOMMENDED

Assessment by Dimension:

Key Diagnostic Observations:

• The patient is breathing steadily. The company is active, compliant, and shows no signs of acute distress. No liquidation, administration, or receivership proceedings. No overdue filings. This is a fundamentally healthy corporate entity.

• The heartbeat is regular but unmeasured. Without access to the actual financial statements (balance sheet, P&L, cash flow), we cannot quantify liquidity ratios, profitability margins, or leverage levels. The absence of red flags is reassuring, but it is not the same as confirmed good health.

• The constitution is strong. £100,500 in share capital, 25 years of operation, and group ownership suggest a well-nourished corporate body with access to resources.

• Recent board changes are a mild fever. The resignation of two directors in February 2026 — including a long-serving British director (Xxxxxx Xxxxxxxxname shown to subscribers) — warrants attention. This could simply reflect normal succession planning or group-level reorganisation, but it should be monitored.

4. PROGNOSIS

Short-Term Outlook (Next 12 Months): FAVOURABLE

• Continued operations with no immediate threat to solvency
• Group support provides a buffer against sector headwinds
• Compliance track record suggests continued orderly filing

Medium-Term Outlook (1–3 Years): CAUTIOUSLY POSITIVE

• Sector exposure to automotive/industrial demand creates cyclical risk
• Energy costs and raw material prices remain key variables
• Parent company strategy will determine investment and growth trajectory
• Board stability should be monitored following recent departures

Key Risk Factors:

1. Economic Downturn: Reduced demand for cast metal components in automotive and industrial sectors
2. Cost Inflation: Energy-intensive manufacturing processes are exposed to UK energy price volatility
3. Group Restructuring: Parent-level decisions could affect the UK operation's scope and investment
4. Key Person Risk: With only 3 directors, the departure of additional board members could strain governance

5. RECOMMENDATIONS

Immediate Actions (Next 30 Days)

1. Obtain and Review Full Financial Statements: Request the latest filed accounts (FYE 31 December 2025) from Companies House or the company directly. Analyse: - Current ratio (current assets ÷ current liabilities) — target above 1.5 - Debt-to-equity ratio — assess leverage - Gross and net profit margins — compare to sector benchmarks - Cash position and working capital trends

2. Clarify Board Changes: Understand the circumstances around the February 2026 resignations. Confirm these were orderly departures (retirement, restructuring) rather than dispute-driven exits.

3. Verify Group Support Arrangements: Confirm the nature of any intercompany funding, guarantees, or shared services agreements with Dynacast UK Parent Limited.

Ongoing Monitoring (Quarterly)

4. Track Sector Indicators: Monitor non-ferrous metal prices (aluminium, zinc, magnesium), UK energy costs, and automotive production volumes.

5. Review Companies House Filings: Set alerts for new charges, director appointments/resignations, and changes in PSC structure.

6. Assess Working Capital Cycle: Once financial data is available, calculate debtor days, creditor days, and inventory turnover. Manufacturing businesses can face cash flow strain even when profitable.

Strategic Considerations (Annually)

7. Diversification Assessment: Evaluate the customer base concentration. If heavily dependent on automotive, consider growth in aerospace, medical devices, or renewable energy components.

8. Energy Efficiency Review: Given energy-intensive operations, assess opportunities for efficiency improvements or renewable energy investments to reduce cost exposure.

9. Succession Planning: With a lean board of three, ensure robust succession planning to mitigate key person risk.

FINAL VERDICT

DYNACAST (UK) LIMITED presents as a well-established, compliant, and stable manufacturing subsidiary with strong corporate governance and no acute distress signals. The primary limitation of this assessment is the absence of detailed financial statement data, which prevents full verification of liquidity and profitability metrics.

The company is not currently exhibiting symptoms of financial illness, but a complete blood panel (full accounts) is required for a definitive diagnosis. The recent board changes and sector-specific risks warrant ongoing observation.

Names of the people mentioned are shown to subscribers. See subscription